270 related articles for article (PubMed ID: 23197199)
21. [Not Available].
Cedef
Ann Dermatol Venereol; 2018 Mar; 145 Suppl 1():S186-S188. PubMed ID: 29475620
[No Abstract] [Full Text] [Related]
22. How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndrome.
Sethi TK; Montanari F; Foss F; Reddy N
Br J Haematol; 2021 Nov; 195(3):352-364. PubMed ID: 33987825
[TBL] [Abstract][Full Text] [Related]
23. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathological differential diagnosis of mycosis fungoides/Sézary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma].
Johno M; Ono T
Nihon Rinsho; 2000 Mar; 58(3):660-4. PubMed ID: 10741142
[TBL] [Abstract][Full Text] [Related]
25. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
Sausville EA; Eddy JL; Makuch RW; Fischmann AB; Schechter GP; Matthews M; Glatstein E; Ihde DC; Kaye F; Veach SR
Ann Intern Med; 1988 Sep; 109(5):372-82. PubMed ID: 3408055
[TBL] [Abstract][Full Text] [Related]
26. Mycosis fungoides. Diagnosis and pathogenesis.
Barcos M
Am J Clin Pathol; 1993 Apr; 99(4):452-8. PubMed ID: 8475912
[No Abstract] [Full Text] [Related]
27. [Diagnosis of malignant cutaneous lymphomas].
Sterry W
Dtsch Med Wochenschr; 1988 Feb; 113(5):184-9. PubMed ID: 3276493
[No Abstract] [Full Text] [Related]
28. Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and Sézary syndrome in the southeastern United States: a single-institution cohort.
Desai M; Liu S; Parker S
J Am Acad Dermatol; 2015 Feb; 72(2):276-85. PubMed ID: 25458019
[TBL] [Abstract][Full Text] [Related]
29. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
Hoppe RT; Wood GS; Abel EA
Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
[TBL] [Abstract][Full Text] [Related]
30. It is time to adopt a multicolor immunophenotyping approach to evaluate blood for Sézary syndrome and mycosis fungoides.
Craig FE
Cytometry B Clin Cytom; 2021 Mar; 100(2):125-128. PubMed ID: 32083391
[No Abstract] [Full Text] [Related]
31. Scleromyxedematous Changes in a Patient With Long-Standing Mycosis Fungoides Who Progressed to Sézary Syndrome.
Miraflor AP; Pulitzer MP; Myskowski PL; Geller S
Am J Dermatopathol; 2019 Nov; 41(11):e139-e143. PubMed ID: 31169525
[TBL] [Abstract][Full Text] [Related]
32. [Clinical characteristics of mycosis fungoides and Sézary syndrome].
Krc L; Dobesová J; Bucek M; Dusek J; Macák J; Galuszková D; Jurysek O
Vnitr Lek; 1997 May; 43(5):285-9. PubMed ID: 9601850
[TBL] [Abstract][Full Text] [Related]
33. Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and Sézary syndrome.
Jothishankar B; Almazan T; Kim Y; Liauw S; Smith S; Kline J; Abdulla F
Br J Haematol; 2019 Jul; 186(2):377-379. PubMed ID: 30937886
[No Abstract] [Full Text] [Related]
34. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
Safai B
Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870
[No Abstract] [Full Text] [Related]
35. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
Meyerson HJ; Awadallah A; Pavlidakey P; Cooper K; Honda K; Miedler J
Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS).
Jothishankar B; Venkataraman G; Goldberg RC; Abdulla F
Ann Diagn Pathol; 2019 Dec; 43():151404. PubMed ID: 31629155
[No Abstract] [Full Text] [Related]
37. [Diagnostics of primary cutaneous lymphomas].
Felcht M; Hillen U; Klemke CD
Hautarzt; 2017 Sep; 68(9):696-701. PubMed ID: 28779267
[TBL] [Abstract][Full Text] [Related]
38. Is bone marrow biopsy necessary in patients with mycosis fungoides and Sézary syndrome? A histological and molecular study at diagnosis and during follow-up.
Beylot-Barry M; Parrens M; Delaunay M; Thiebault R; Vergier B; DeMascarel A; Dubus P; Beylot C; Merlio JP
Br J Dermatol; 2005 Jun; 152(6):1378-9. PubMed ID: 15949023
[No Abstract] [Full Text] [Related]
39. Mycosis fungoides: classic disease and variant presentations.
Howard MS; Smoller BR
Semin Cutan Med Surg; 2000 Jun; 19(2):91-9. PubMed ID: 10892710
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructural morphometry in the diagnosis of mycosis fungoides and Sézary's syndrome.
Payne CM
Clin Dermatol; 1991; 9(2):187-203. PubMed ID: 1747854
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]